share price, page-16

There's just a lack of interest in tis atm, and lots of other biotechs are looking hot.

They say that all is on track for sales to start in June, which is fantastic. However the lack of detail hasn't got investors excited yet. I'm sure investors will become excited about tis again, once we have some real good news (like european approval).

As for a cap raising, I don't think it is needed. Most of our costs are before sales start, like stocking up, approval applications etc. However if more cash is needed, remember that Quantillies offer non diluting funding options as part of the working with them (eg loans offset by future sales).

There are times when investors are all over a stock, and times when they are not interested (or watching to see how low something can go).

But once it's clear that sales will start, then I'm sure the sp will rise, and rise on substance rather than the usual hot air.

cheers